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Background: Lymphedema is a common complication of axillary dissection for breast cancer. We investigated
whether manual lymphatic drainage (MLD) could prevent or manage limb edema in women after breast-cancer
surgery.
Methods: We performed a systematic review and meta-analysis of published randomized controlled trials (RCTs) to
evaluate the effectiveness of MLD in the prevention and treatment of breast-cancer-related lymphedema. The
PubMed, EMBASE, CINAHL, Physiotherapy Evidence Database (PEDro), SCOPUS, and Cochrane Central Register of
Controlled Trials electronic databases were searched for articles on MLD published before December 2012, with no
language restrictions. The primary outcome for prevention was the incidence of postoperative lymphedema. The
outcome for management of lymphedema was a reduction in edema volume.
Results: In total, 10 RCTs with 566 patients were identified. Two studies evaluating the preventive outcome of MLD
found no significant difference in the incidence of lymphedema between the MLD and standard treatment groups,
with a risk ratio of 0.63 and a 95% confidence interval (CI) of 0.14 to 2.82. Seven studies assessed the reduction in
arm volume, and found no significant difference between the MLD and standard treatment groups, with a
weighted mean difference of 75.12 (95% CI, −9.34 to 159.58).
Conclusions: The current evidence from RCTs does not support the use of MLD in preventing or treating
lymphedema. However, clinical and statistical inconsistencies between the various studies confounded our
evaluation of the effect of MLD on breast-cancer-related lymphedema.
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Lymphedema is defined as persistent tissue swelling
caused by the blockage or absence of lymph drainage
[1]. Lymphedema is a major concern for patients under-
going axillary lymph-node dissection for the treatment
of breast cancer. The incidence of lymphedema at 12
months after breast surgery ranges from 12% to 26%
[2,3]. Lymphedema may result in cosmetic deformity,
loss of function, physical discomfort, recurrent episodes* Correspondence: kelvintam@h.tmu.edu.tw
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reproduction in any medium, provided the orof erysipelas ,and psychological distress [4,5]. Thus, an
effective treatment for lymphedema is necessary.
Previous surgical techniques for the treatment of lym-
phedema aimed to reduce limb volume using a debulking
resection approach. With the advent of microsurgery, use
of multiple lymphatic-venous anastomoses has become
the most common surgical treatment [6]. However, con-
vincing evidence of the success of lymphatic-venous anas-
tomoses has not been demonstrated. Thus, most patients
with lymphedema choose non-surgical treatments, such as
the use of elastic stockings, especially in early stages of
lymphedema [7].
Complex decongestive physiotherapy (CDP) is likely to
reduce upper limb lymphedema in patients with breastLtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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methods is limited [8-10]. Compression bandaging, man-
ual lymphatic drainage (MLD), physical exercise to main-
tain lymphatic flow, and skin care are combined in CDP
[11,12]. In MLD, specialized rhythmic pumping techni-
ques are used to massage the affected area and enhance
the lymph flow. Gentle skin massage is thought to cause
superficial lymphatic contraction, thereby increasing
lymph drainage [13].Vodder originally suggested the use
of range-of-motion exercises to relieve various types of
chronic edema, such as sinus congestion and catarrh [14],
and the use of MLD has become a common treatment for
lymphedema worldwide, especially in European hospitals
and clinics.
To date, several studies have been published investigat-
ing the effects of MLD in preventing and treating lym-
phedema after breast-cancer surgery [15-18]. However,
these studies have been inconclusive, probably because of
small sample sizes. Therefore, we conducted a systematic
literature review and meta-analysis of randomized con-
trolled trials (RCTs) to evaluate the effectiveness of MLD
in the prevention and treatment of breast-cancer-related
lymphedema.Methods
Selection criteria
We reviewed RCTs or quasi-RCTs from the literature that
evaluated the outcome of MLD in preventing and treating
breast-cancer-related lymphedema. For inclusion in our
study, the trials were required to describe: 1) the inclusion
and exclusion criteria used for patient selection, 2) the
MLD technique used, 3) the compression strategy used, 4)
the definition of lymphedema, and 5) the evaluation of
lymphedema severity. We excluded trials that met as least
one of the following criteria: 1) patients had not received
axillary lymph-node dissection (such as in studies in which
only sentinel node sampling was used), 2) the clinical out-
comes had not been clearly stated, or 3) duplicate report-
ing of patient cohorts had occurred.Search strategy and study selection
Studies were identified by keyword searches of the follow-
ing electronic databases: PubMed, EMBASE, CINAHL,
PEDro (Physiotherapy Evidence Database), SCOPUS,
Cochrane Central Register of Controlled Trials, and the
ClinicalTrials.gov registry (http://clinicaltrials.gov/). The
following terms and Boolean operator were used in MeSH
and free-text searches: ‘manual lymph drainage’, ‘breast
cancer OR neoplasm’, ‘lymphoedema OR lymphedema’.
The ‘related articles’ facility in PubMed was used to
broaden the search. No language restrictions were applied.
The final search was performed in December 2012. We
attempted to identify additional studies by searching thereference sections of any relevant papers and contacting
known experts in the field.
Data extraction and methodological quality appraisal
Two authors (K-WT and T-WH) independently extracted
details of the RCTs pertaining to the participants, inclusion
and exclusion criteria, manual lymph-drainage techniques
used, arm lymphedema parameters, and complications.
The individually recorded decisions of the two reviewers
were compared, and any disagreements were resolved
based on the evaluation of a third reviewer (S-HT).
The two authors independently appraised the methodo-
logical quality of each study based on: 1) adequacy of the
randomization, 2) allocation concealment, 3) blinding, 4)
duration of follow-up, 5) number of drop-outs, and 6) per-
formance of an intention-to-treat (ITT) analysis.
Outcomes assessments
The efficacy of MLD was evaluated by the incidence of
lymphedema and the reduction in the volume of the
patient’s arm at 1, 3, 6, 9 and 12 months after MLD treat-
ment. The arm volume was assessed by submerging each
arm in a container filled with water, and measuring the
volume (ml) displaced [19]. The absolute edema volume
was defined as the difference in volume between the arm
with lymphedema and the contralateral arm [18]. The fol-
lowing various definitions for lymphedema were used in
the studies analyzed: a difference in volume of greater than
10% between the affected arm and contralateral arm
[17,18,20]; an increase of 200 ml or more in the volume of
the affected arm compared with the pre-surgery volume of
the same arm [16]; and an increase of 20 mm or more in
the circumference of the affected arm compared with the
pre-surgery circumference of the same arm [16,21].
Statistical analysis
Statistical analysis was conducted using Review Manager
software (version 5.1;Cochrane Collaboration, Oxford,
UK). The meta-analysis was performed in accordance
with the Preferred Reporting Items for Systematic
Reviews and Meta-analysis (PRISMA) guidelines [22].
When necessary, standard deviations (SDs) were esti-
mated based on the reported confidence interval (CI)
limits, standard error, or range values [23]. The effect
sizes of dichotomous outcomes were calculated as risk
ratios (RR), and the mean difference was calculated for
continuous outcomes. The precision of an effect size
was calculated as the 95% CI. A pooled estimate of the
RR was calculated using the DerSimonian and Laird
random-effects model [24]. This provided relatively wide
CIs and an appropriate estimate of the average treatment
effect for trials that were statistically heterogeneous,
resulting in a conservative statistical claim. The data
were pooled only for studies that exhibited adequate
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geneity was assessed using the I2 test, with I2 quantifying
the proportion of the total outcome variability that was
attributable to variability among the studies.
Results
Characteristics of the trials
The process by which we screened and selected the trials is
shown in a flow chart (Figure 1). Our initial search yielded
170 studies, of which 29 were deemed ineligible after
screening of titles and abstracts. Another 141 reports were
excluded from our final analysis for the following reasons:
58 were review articles, 3 were animal studies, 18 had used
different comparisons, 33 discussed different topics, and 19
were not randomized trials. The remaining 10 eligible
RCTs [15-18,20,21,25-28] were included in our analysis.
The 10 trials were published between 1998 and 2011,
and had sample sizes ranging from 24 to 158 patients
(Table 1). All patients had undergone mastectomy with
axillary lymph-node dissection, and patient age ranged
from 25 to 77 years.
Most of the trials had assessed MLD treatment using
the Vodder method [14]. MLD was performed by spe-
cially trained physiotherapists, and was followed by skin
care with moisturizers, multilayered short-stretch banda-
ging with appropriate padding, and exercise. The MLD
extended to the neck, the anterior and posterior trunk,
and the swollen arm. One study did not fully describe
the MLD method that was used [15]. In addition to the
use of sleeve or glove compression, standard therapies
also included educational information and recommenda-
tions on lymphedema, instructions for physical exercises
to enhance lymph flow, education in skin care, and
safety precautions. Across all ten studies, the two treat-
ment groups were comparable for patient age and the dur-
ation of MLD (Table 1). Most of the included trials hadTrials selected for inclusion
(n=10)
Search for potentially relevant trials 
(n=170)
Trials retrieved for further evaluation 
(n=141)
Figure 1 Flowchart of the selection of the clinical trials.investigated whether the addition of MLD to the standard
therapy after breast-cancer treatment improved clinical
outcomes in women with lymphedema. Two trials investi-
gated the preventive effect of MLD on the development of
lymphedema in women after breast-cancer surgery [16,21].
Two trials measured the effects of simple lymphatic drain-
age (SLD) versus MLD on lymphedema of the arm [20,27].
One trial compared the outcomes of MLD with or without
sequential pneumatic compression (SPC) [28].
We assessed the methodological quality of the included
trials (Table 2). Five studies reported acceptable methods
of randomization [16,21,25-27], four trials described the
method of allocation concealment [16,25-27] three studies
reported the blinding of the outcome assessors [16,21,25],
and one trial reported the blinding of the patients [26].
Three studies used an ITTanalysis [15,16,28]. The number
of patients lost to follow-up was acceptable at less than
20% in all 10 studies.
Incidence of lymphedema
The incidence of lymphedema was determined in two
trials that evaluated the preventive outcome of MLD in
patients after breast-cancer surgery [16,21]. No signifi-
cant differences were found between the MLD and
standard treatment groups, with an RR of 0.63 (95% CI,
0.14 to 2.82) at 1 month [21] and 3 months [16,21] post-
operatively (Figure 2). The value of I2 was 84%, indicat-
ing significant heterogeneity across the studies.
Reduction in lymphedema volume
Seven studies provided data on the reduction in lymphe-
dema volume [15,17,18,20,25,27,28] after MLD treat-
ment. In each of these studies, the volume of the arm
was measured at the beginning of treatment, and at 1, 3,
and 12 months after treatment using water displacement
volumetry. To facilitate our comparisons, we convertedStudies excluded (n=29)
Not relevant (n=29)
Studies excluded (n=131)
Not randomized (n=19)
Review only (n=58)
Different comparisons (n=18)
Different topic (n=33)
Not human (n=3)
Table 1 Characteristics of studies that fulfilled the inclusion criteria for meta-analysis
Reference Inclusion criteria No. of
patients
Age, years,
(mean ± SD)
Intervention
Treatment
Andersen, 2000 Symptoms of lymphedema; 20 mm
circumference or 200 ml volume difference
between arms
C: 22 C: 56 (29 to 77)a C: Sleeve and glove compression 32 to
40 mmHg + exercises + skin care + safety
precautions
I: 20 I: 53 (25 to 73) I: C + MLD 8 times in 2 weeks
Didem, 2005 2-50 mm circumference difference between
arms; lymphedema > 12 months after surgery
C: 26 C: 54.7 ± 12.1 C: Bandaging; elevation; head, neck and shoulder
exercise, 3 days/week for 4 weeks
I: 27 I: 53.1 ± 3.05 I: C + MLD
Johansson, 1998 >10% volume difference between arms C: 12 C: 57.5 (47.5-69.5)a C: Sleeve compression for 2 weeks + SPC 40 to
60 mmHg 2 hours/day for 2 weeks
I: 12 I: 64 (52.5-69.5) I: Sleeve compression 2 weeks + MLD for
5 days/weeks for 2 weeks
Johansson, 1999 >10% volume difference between arms C: 18 C: 64 ± 12 C: Bandage compression for 3 weeks
I: 20 I: 58 ± 12 I: C + MLD applied for 5 days during final weeks
McNeely, 2004 150 ml volume difference between arms C: 24 C: 58 ± 13 C: Bandage compression for 4 weeks
I: 21 I: 63 ± 13 I: C + MLD for 45 minutes/day 5 days/week for
4 weeks
Sitzia, 2002 Lymphedema of one arm secondary to
treatment for breast cancer
C: 13 C: 75 ± 10.2 C: SLD 30 minutes/day, 5 days/weeks for
2 weeks + bandage + exercises
I: 15 I: 68 ± 10.4 I: MLD 90 minutes/day, 5 days/week for 2 weeks
+ bandage + exercises
Williams, 2002 >10% volume difference between arms G1: 15 A: 63 ± 13 G1: MLD for 3 weeks, then no treatment for
6 weeks, then SLD for 3 weeks
G2: 16 B: 58 ± 13 G2: SLD for 3 weeks, then no treatment for
6 weeks, then MLD for 3 weeks
Szolnoky, 2009 Lymphedema >12 months after surgery G1: 13 G1: 54.8 G1: MLD 60 minutes/day, 5 days/week for
2 weeks
G2: 14 G2: 56.6 G2: MLD for 30 minutes/day then SPC 50 mmHg
for 30 minutes/day, 5 days/week for 2 weeks
Prevention
Devoogdt, 2011 Patients after breast-cancer surgery C: 81 C: 54.5 ± 11.1 C: Exercise therapy 30 minutes/session
I: 77 I: 55.8 ± 12.5 I: C + MLD 30 minutes/session for 40 sessions
Torres Lacomba,
2010
Patients after breast-cancer surgery C: 60 C: 52.9 ± 12.5 C: Educational strategy
I: 60 I: 52.9 ± 10.7 I: C + MLD + massage + exercise
Abbreviations: C, control; I, intervention; G, group; MLD, manual lymphatic drainage; SLD, simple lymph drainage; SPC, sequential pneumatic compression.
Values are mean ± standard deviation, except for amean (range).
Table 2 Assessment of methodological quality of included trials
Study Study design Data analysis Allocation generation Allocation concealment Blinding Lost to follow-up
Andersen, 2000 RCT ITT Unclear Unclear None reported 9.5% at 12 months
Devoogdt, 2011 RCT ITT Adequate Adequate Assessor blinded 4% at 12 months
Didem, 2005 RCT PP Sealed envelopes Adequate Patient blinded 5.4% at 1 months
Johansson, 1998 RCT PP Unclear Unclear None reported None
Johansson, 1999 RCT PP Inadequate Unclear None reported None
McNeely, 2004 RCT PP Computer-generated Adequate Assessor blinded 11.1% at 1 months
Williams, 2002 RCT crossover PP Unclear Unclear None reported None
Sitzia, 2002 RCT PP Computer-generated Adequate None reported 3.6% at 2 weeks
Szolnoky, 2009 RCT ITT Unclear Unclear None reported None
Torres Lacomba, 2010 RCT PP Computer-generated Unclear Assessor blinded 3.3% at 12 months
Abbreviations: PP, per-protocol; RCT, randomized controlled trial; ITT, intention-to-treat.
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Study or Subgroup
Devoogdt  2011
Torres Lacomba 2010
Total (95% CI)
Total events
Heterogeneity: Tau² = 0.99; Chi² = 6.17, df = 1 (P = 0.01); I² = 84%
Test for overall effect: Z = 0.61 (P = 0.54)
Events
18
4
22
Total
77
59
136
Events
15
14
29
Total
81
57
138
Weight
54.0%
46.0%
100.0%
M-H, Random, 95% CI
1.26 [0.69, 2.32]
0.28 [0.10, 0.79]
0.63 [0.14, 2.82]
MLD Standard Risk Ratio Risk Ratio
M-H, Random, 95% CI
0.01 0.1 1 10 100
Favours MLD Favours standard
Figure 2 Forest plot of the comparison of the effect of standard treatment with or without manual lymphatic drainage (MLD) on the
incidence of post-mastectomy lymphedema from 2 clinical trials. The first author names and the 95% confidence interval (CI) are included.
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treatment to absolute volume (ml)reductions. Our ana-
lysis showed that there were no significant differences
between the two treatment groups (weight mean differ-
ence 75.12; 95% CI −9.34 to 159.58), and that significant
heterogeneity in the reductions in arm volume occurred
between the trials (Figure 3).
The data reported by Didem et al. was not pooled be-
cause the method used to measure the change in lymphe-
dema volume was not reported. However, that groups
reported that lymphedema was more effectively reduced in
the MLD treatment group than in the standard physiother-
apy group (P<0.05) [26]. In addition, a study of the effects
of MLD with or without SPC reported no significant differ-
ence in arm volume reduction between the treatment
groups at 1 and 2 months after treatment [28].
Discussion
A physical treatment program combining MLD, skin
care, exercise, compression bandaging, and sleeve or
stocking compression is recognized as providing optimal
lymphedema management [29]. Three systematic reviews
concluded that combined physical therapy provides ef-
fective treatment for lymphedema [30-32]. However, theStudy or Subgroup
Andersen 2000
Johansson 1998
Johansson 1999
McNeely 2004
Sitzia 2002
Williams 2002
Total (95% CI)
Heterogeneity: Tau² = 7074.07; Chi² = 126.53, df = 5 (P < 0.00001); I² = 96
Test for overall effect: Z = 1.74 (P = 0.08)
Mean
163.2
159
195
241
1,147.5
71
SD
28.6
325
378
228
143.5
28.1
Total
20
12
20
21
15
29
117
Mean
216.6
25
250
244
764.1
30
SD
32.2
439
538
197
121.2
17.1
Total
22
12
18
24
13
31
120
We
25
5
6
16
19
26
100
MLD Standard
Figure 3 Forest plot of comparison of the effect of compression thera
reduction in post-mastectomy lymphedema volume from 6 clinical tr
and the 95% confidence interval (CI) are included.effectiveness of the individual components of such pro-
grams has not been clearly established. The relatively
high cost of MLD compared with compression banda-
ging warrants assessment of the efficacy of these individ-
ual components. The results of our systematic review
and meta-analysis did not show a significant benefit for
MLD in reducing lymphedema volume. Although indi-
vidual studies reported advantages associated with MLD,
methodological inconsistencies between the studies con-
founded our attempts to conduct an overall comparison
of the effects of MLD across the studies.
The published reports of the effectiveness of MLD are
conflicting. One prospective study of 682 individual cases
in a single lymphology unit evaluated various treatments
for lymphedema. The results indicated that the risk of fail-
ure for lymphedema therapy after intensive decongestive
physiotherapy was primarily associated with younger age,
higher weight, and higher body mass index. By contrast,
elastic sleeve and multilayer bandaging treatments were
associated with a reduced risk of treatment failure, whereas
the use of MLD as an adjunct to those therapeutic compo-
nents was not [33]. One retrospective study of 208 patients
with lymphedema receiving palliative care showed clinical
improvement in the intensity of pain and dyspnea in most%
ight
.9%
.8%
.1%
.6%
.4%
.1%
.0%
IV, Random, 95% CI
-53.40 [-71.79, -35.01]
134.00 [-175.04, 443.04]
-55.00 [-353.69, 243.69]
-3.00 [-128.38, 122.38]
383.40 [285.35, 481.45]
41.00 [29.13, 52.87]
75.12 [-9.34, 159.58]
Mean Difference Mean Difference
IV, Random, 95% CI
-1000 -500 0 500 1000
Favours standard Favours MLD
py with or without manual lymphatic drainage (MLD) on the
ials. The first author names, the standard deviations (SDs) of the mean,
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RCT design is that allocation bias is minimized, resulting
in a balance between the known and unknown confound-
ing variables in the assignment of treatments. Systematic
review and meta-analysis of the clinical outcomes of ther-
apy, as reported in the summaries of the RCT results to
date, may help identify the effects that are common to
these trials. Such research more clearly distinguishes the
effects of MLD in preventing and managing lymphedema.
Our meta-analysis examined the results of six studies
that assessed the effects of MLD in patients with post-
mastectomy lymphedema, compared with compression
therapy [15,17,18,20,25,27]. Compression bandaging has
been shown to be effective in managing lymphedema.
Badger et al. conducted an RCT to compare compres-
sion bandaging for 18 days followed by a compression
garment (treatment group) versus the compression gar-
ment only (comparison group). These authors reported a
significantly greater reduction in limb volume at 24 weeks
in the treatment group compared with the comparison
group [4]. The studies that we reviewed had investigated
several types of compression therapy. McNeely et al.
found that the figure-of-eight method was more effective
in maintaining the correct bandage position, and was also
more comfortable for the patient, compared with the
spiral-bandaging method [25]. McNeely et al. replaced the
bandages 5 times/week over the 4-week treatment period,
whereas Johansson et al. replaced the compression ban-
dage every 2 days over a 3-week period [18].
Sequential intermittent pneumatic compression is an-
other nonsurgical treatment for lymphedema [35]. Szolnoky
et al. investigated whether a combination of SPC treat-
ments and MLD improved the outcome of CPD treatment
for women with secondary lymphedema [28]. Thus, in the
studies we investigated, there was a high level of heterogen-
eity regarding the variables measured to represent the re-
duction in lymphedema volume.
We included two studies in our analysis that compared
MLD with SLD in the treatment of breast-cancer-related
lymphedema [20,27]. Although MLD and SLD involve
the same principles, SLD is a less complex technique
that uses simplified hand movements in a set sequence.
SLD can also be applied by the patient or a caregiver
without requiring specialized training [27]. The results
of both studies showed that MLD significantly reduced
excess limb volume compared with SLD.
Of the ten RCT studies that we reviewed in our meta-
analysis, only two investigated the effects of MLD for pre-
venting lymphedema after breast-cancer surgery [16,21].
Devoogdt et al. evaluated the effect of MLD used in com-
bination with exercise therapy and instructional guidelines
for lymphedema prevention in 160 patients with breast can-
cer and unilateral axillary lymph-node dissection, who were
stratified by body mass index and axillary irradiation [16].Patients received exercise therapy plus MLD or exercise
therapy only for 6 months; the results showed no significant
difference in the prevention of lymphedema between the
two groups [16]. By contrast, Torres Lacomba et al. used
MLD, scar-tissue massage, and progressive active and
action-assisted shoulder exercises postoperatively in pa-
tients who had undergone breast-cancer surgery, whereas
their control group received only instructional guidelines
for lymphedema prevention Torres Lacomba et al. found a
significant difference in secondary lymphedema between
the groups at 1 year post-surgery [21]. However, the indi-
vidual contribution of MLD to the prevention of secondary
lymphedema was unclear.
Variability in clinical factors and non-uniform reporting
of clinical parameters contributed to the heterogeneity be-
tween the studies that we reviewed. First, the technique,
duration, and frequency of MLD differed across the stud-
ies, and one study did not report the technical details of
their MLD method [15]. Second, the experience of the
physiotherapist and the characteristics of the individual
patient can affect clinical outcomes. For example, patients
in the study by Sitzia et al. were older than those in the
other trials that we reviewed [27]. Third, the compression
and exercise strategies also differed greatly between the
studies that we reviewed (Table 1); for example, the con-
trol group in the study by Torres Lacomba et al. received
only educational instructions [21]. Fourth, the methods
used for evaluating the reduction in arm volume were also
different between the studies, rendering our assessment
vulnerable to measurement bias.
The strengths of our review include our comprehensive
search for relevant studies, the systematic and explicit ap-
plication of eligibility criteria, the careful consideration of
study quality, and our rigorous analytical approach. How-
ever, our review was limited by the methodological quality
of the original studies (Table 2). First, several trials were
small, and one study recruited only 12 patients in each
treatment group [17], diminishing the statistical power of
their analysis. Second, only half of the studies included in
our analysis reported adequate randomization in the
study-group allocation [16,21,25-27]. Third, in seven stud-
ies, the assessment staff were not blinded to the outcomes
[15,17,18,20,26-28]. Furthermore, most of the investigators
analyzed their data according to the per-protocol
principle, which may have biased their evaluations of the
effect of MLD.
An ongoing study of 58 patients with post-mastectomy
lymphedema is evaluating the effectiveness of MLD as an
adjunct to standard treatment for reducing the volume of
the affected arm and the consequent effects on patient
quality of life and physical limitations [ClinicalTrials.gov
identifier NCT01152099] [36]. We await the results to de-
termine whether this will provide more evidence for clin-
ical practice.
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In conclusion, our meta-analysis indicated that the addition
of MLD to compression and exercise therapy for the treat-
ment of lymphedema after axillary lymph-node dissection
for breast cancer is unlikely to produce a significant reduc-
tion in the volume of the affected arm. We found no sig-
nificant difference in the incidence of lymphedema in
patients treated with or without MLD. Overall, the meth-
odological quality of the studies that we reviewed was poor.
Based on the results of our meta-analysis, we cannot rec-
ommend the addition of MLD to compression therapy for
patients with breast-cancer-related lymphedema.
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